Gastric Helicobacter pylori infection eradication rate with levofloxacin based regimen and comparison with standard clarithromycin regime
Not Applicable
Recruiting
- Conditions
- Helicobacter pylori infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
- Registration Number
- IRCT20170803035490N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Age from 18 to 65 yrs
With epigastric problems
Exclusion Criteria
PPI consumption in 2 wks ago
Antibiotic use in 4 wks ago
GI bleeding
Allergy to antibiotics
Drug intolerance
Unresponsiveness to standard clarithromycin regimen( duo to ethic consideration)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori eradication rate in stomach. Timepoint: One month after therapy. Method of measurement: Stool antigen test.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: during and after intervention. Method of measurement: monitoring for side effects.